{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T22:10:28Z","timestamp":1713996628844},"reference-count":23,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1189,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/j.1365-2710.2012.01359.x","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T02:41:49Z","timestamp":1338432109000},"page":"647-651","source":"Crossref","is-referenced-by-count":15,"title":["A comprehensive 4-year survey of adverse drug reactions using a network-based hospital system"],"prefix":"10.1155","volume":"37","author":[{"given":"C.-J.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.-F.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-P.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-S.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,5,30]]},"reference":[{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB1|cit1","volume-title":"International drug monitoring: the role of the hospital","author":"World Health Organization","year":"1969"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB2|cit2","first-page":"18","volume-title":"Textbook of adverse drug reactions","author":"Rawlins","year":"1991"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB3|cit3","volume-title":"Dark remedy: the impact of thalidomide and its revival as a vital medicine","author":"Stephens","year":"2001"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB4|cit4","first-page":"761","volume-title":"Clinical aspects of immunology","author":"Coombs","year":"1975"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2500\/108854194778700713","article-title":"Drug allergy and protocols for management of drug allergies","volume":"15","author":"Patterson","year":"1994","journal-title":"Allergy Proc"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1067\/mai.2003.93","article-title":"Drug allergy","volume":"111","author":"Gruchalla","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"778.e1","DOI":"10.1016\/j.amjmed.2009.01.034","article-title":"Self-reported antibiotic allergy incidence and prevalence: age and sex effects","volume":"122","author":"Macy","year":"2009","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby","year":"1986","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","article-title":"Self-reported drug allergy in a general adult Portuguese population","volume":"34","author":"Gomes","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(91)90216-K","article-title":"Familial occurrence of hypersensitivity to phenytoin","volume":"91","author":"Gennis","year":"1991","journal-title":"Am J Med"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2222.2007.02870.x","article-title":"Drug allergy claims in children: from self-reporting to confirmed diagnosis","volume":"38","author":"Rebelo Gomes","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archderm.136.7.849","article-title":"Antibiotic rashes in children: a survey in a private practice setting","volume":"136","author":"Ibia","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2008.12.034","article-title":"The use of penicillin skin testing to assess the prevalence of penicillin allergy in an emergency department setting","volume":"54","author":"Raja","year":"2009","journal-title":"Ann Emerg Med"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1081-1206(10)60882-4","article-title":"Penicillin skin testing in patients with a history of beta-lactam allergy","volume":"98","author":"del Real","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00325481.1995.11946035","article-title":"Allergic drug reactions. How to minimize the risks","volume":"98","author":"Bernstein","year":"1995","journal-title":"Postgrad Med"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/j.1365-2710.2012.01359.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2012.01359.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2012.01359.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T21:44:11Z","timestamp":1713995051000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2012.01359.x"}},"subtitle":["Hospital-based adverse reaction reporting system"],"short-title":[],"issued":{"date-parts":[[2012,5,30]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2012.01359.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,30]]}}}